sa.okonkwo

TL2 · Groningen

Contributes reviews on supplier material. Based in Groningen.

Joined 7 May 2025 · last posted 1d

82 posts, newest first. Showing up to 150.

System suitability injections: if they failed, the run did not happen — the long version Replied, post #7 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 13 likes Everything in post #3 holds. The case it does not cover is the one I have. System suitability is not paperwork. If the replicate injections failed, the run did not…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #93 · Sourcing › Independent verification · 15 Jul 2026 · 11 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #80 · Meta › Announcements · 10 Jul 2026 · 0 likes Picking up post #77: that is the part I would want checked first. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent…
Pooling trials with different estimands Replied, post #68 · Evidence › Meta-analyses · 3 Jul 2026 · 1 like A meta-analysis of four small trials is not stronger evidence than one adequately powered trial, whatever the summary statistic looks like. It took me longer than it…
Request: a per-category review queue Replied, post #71 · Meta › Feature requests · 1 Jul 2026 · 2 likes What I can speak to on per-category review queue is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Bioimpedance and hydration: why the number moves Replied, post #66 · Outcomes › Body composition · 26 Jun 2026 · 24 likes Adding the measurement that post #64 says would settle it. Where a facility reports a precision figure for its own machine, that number is more useful than any…
How shortages have affected compounding permissions — does this still hold? Replied, post #17 · Access › Shortages · 24 Jun 2026 · 14 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. For anyone finding this later: the short answer on shortages is that it depends on…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #8 · Practice › Side effects · 20 Jun 2026 · 0 likes That is a cleaner way of putting what I was circling around.
Follow-up: Search filters: what is missing Replied, post #130 · Meta › Site feedback · 16 Jun 2026 · 30 likes The number people quote for Search filters is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #9 · Access › International · 10 Jun 2026 · 7 likes On post #5 — agreed on the reasoning, with one qualification. Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from…
Comparing prices across jurisdictions without misleading yourself Replied, post #43 · Access › Pricing · 6 Jun 2026 · 11 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it. Noting that I have skin in this question and…
A plateau that disappeared when I changed how I measured — the long version Replied, post #45 · Outcomes › Progress reports · 2 Jun 2026 · 0 likes Worth separating two things that post #42 runs together. Posting my plateau numbers with the method attached so they can be discounted properly. Uncontrolled,…
I have no scientific background — can I still follow the analytics categories? Replied, post #12 · Start Here › Welcome · 2 Jun 2026 · 7 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
I have no scientific background — can I still follow the analytics categories? Replied, post #8 · Start Here › Welcome · 25 May 2026 · 23 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Manufacturer assistance programmes and their eligibility rules Replied, post #24 · Access › Pricing · 9 May 2026 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. The most useful pricing posts here are the ones that show the arithmetic rather than the…
The best-written scientific paper you have read Replied, post #35 · Lounge › Off topic · 7 May 2026 · 16 likes The reason best-written scientific paper is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #32 · Practice › Dosing & titration · 4 May 2026 · 32 likes I think the Micro-titration question is answerable and has not been answered, which is a more optimistic position than most of this thread.
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #38 · Analytics › HPLC & UHPLC · 3 May 2026 · 1 like Building on post #37 rather than restating it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #5 · Nutrition & Training › Protein & intake · 24 Apr 2026 · 0 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound. If that reads as pedantic, it is, and…
A parcel stationary at a customs facility for nine days Replied, post #41 · Sourcing › Logistics · 23 Mar 2026 · 0 likes Building on post #39 rather than restating it. I have no financial interest in anything named in this thread and I want to say so before I comment on parcel stationary,…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #26 · Outcomes › Body composition · 19 Mar 2026 · 0 likes Reporting rather than recommending, on Ultrasound and skinfolds. What happened is above. Whether it should have is a different question and not one I am qualified to…
Coming back to: Time to steady state after a dose increase Replied, post #14 · Pharmacology › Pharmacokinetics · 14 Mar 2026 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #112 · Evidence › Study critique · 5 Mar 2026 · 0 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. Happy to…
Second pass at: Identical chromatograms across two different lots Replied, post #12 · Sourcing › Red flags · 17 Feb 2026 · 8 likes Post #9 is right about the mechanism and I think understates the practical bit. Identical chromatograms: I have looked for the primary source twice and failed twice.…
Interpreting a result that disagrees with the supplier's certificate Replied, post #125 · Sourcing › Independent verification · 16 Feb 2026 · 10 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #38 · Evidence › Trials · 15 Feb 2026 · 9 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Follow-up: Search filters: what is missing Replied, post #30 · Meta › Site feedback · 9 Feb 2026 · 22 likes Everything in post #26 holds. The case it does not cover is the one I have. Moderation decisions: if you disagree with a moderation decision, raising it here gives it…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #4 · Compounds › Tirzepatide · 30 Jan 2026 · 1 like The opening post is the version of this I will quote in future. One addition. The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #29 · Practice › Side effects · 28 Jan 2026 · 7 likes Where I would push back on the nausea timeline consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #99 · Practice › Side effects · 14 Jan 2026 · 15 likes Post #98 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
Liver enzymes drifting down and what that usually means Replied, post #42 · Clinical › Bloodwork · 1 Jan 2026 · 17 likes This follows post #41 rather than contradicting it. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
Adsorption to container surfaces and to plastics Replied, post #2 · Pharmacology › Formulation chemistry · 31 Dec 2025 · 0 likes No notes. Posting so the count is not one.
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #11 · Compounds › Semaglutide · 23 Nov 2025 · 29 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
EMA product information as a primary source Replied, post #74 · Regional › European Union · 16 Nov 2025 · 19 likes Reimbursement is decided nationally and varies substantially between member states for the same authorised product.
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #9 · Analytics › Method validation · 24 Oct 2025 · 16 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Inter-laboratory comparison has a well-known answer and a correct answer, and the…
Reading an interaction checker output critically Replied, post #28 · Practice › Interactions · 24 Oct 2025 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Pooling trials with different estimands — what changed since Replied, post #35 · Evidence › Meta-analyses · 10 Oct 2025 · 23 likes Fair, and the limits you put on it are the part I will remember.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 1 like Picking up post #12: that is the part I would want checked first. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #10 · Practice › Side effects · 30 Sep 2025 · 7 likes On nausea timeline the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
A preprint whose numbers changed substantially at publication Replied, post #71 · Evidence › Preprints · 29 Sep 2025 · 16 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #99 · Practice › Side effects · 28 Sep 2025 · 1 like Narrowing post #96, because the general version has more than one answer. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges…
Second pass at: Counter-ion content and its effect on measured mass Started this topic · Analytics › Mass spectrometry · 5 Sep 2025 · 47 likes Second pass at: Counter-ion content and its effect on measured mass Writing it up because I had to work it out twice and would rather nobody else did. Something about…
Request: a diff view for wiki revisions — the long version Replied, post #34 · Meta › Feature requests · 24 Aug 2025 · 1 like Adding a small correction to the diff view for wiki revisions summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
When a preprint is the best available evidence and we say so Replied, post #80 · Evidence › Preprints · 21 Aug 2025 · 5 likes Confirming post #79 from a second method, which matters more than confirming it from a second person. Retractions and corrections do not propagate well from preprint…
How to research a compound with no human data without deceiving yourself Replied, post #111 · Compounds › Other compounds · 4 Aug 2025 · 19 likes Adding the measurement that post #110 says would settle it. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
About the Trials category Replied, post #11 · Evidence › Trials · 21 Jul 2025 · 12 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
A field-by-field walk through a certificate of analysis Replied, post #52 · Analytics › COA interpretation · 15 Jul 2025 · 15 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #16 · Compounds › Retatrutide · 11 Jul 2025 · 22 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #21 · Start Here › How to Ask · 5 Jul 2025 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #108 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 19 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #65 · Clinical › Comorbidities · 14 Jun 2025 · 2 likes Practical answer on hepatic steatosis, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Half-life, steady state, and accumulation worked through Replied, post #116 · Pharmacology › Pharmacokinetics · 14 Jun 2025 · 14 likes This follows post #113 rather than contradicting it. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome…
Follow-up: What other technical communities get right that we do not Replied, post #127 · Lounge › Off topic · 11 Jun 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #34 · Nutrition & Training › Protein & intake · 7 Jun 2025 · 2 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #5 · Compounds › Semaglutide · 24 May 2025 · 15 likes Worth separating two things that the opening post runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
Follow-up: How much fluid is actually needed, and how you would know Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 17 May 2025 · 9 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
Reading a chromatogram someone posted without axes Replied, post #31 · Analytics › HPLC & UHPLC · 10 May 2025 · 8 likes Picking up post #29: that is the part I would want checked first. I changed my mind about reading a chromatogram after someone here asked me for the source and I could…
A well-designed study with a badly written abstract Replied, post #40 · Evidence › Study critique · 23 Apr 2025 · 1 like Sensible. I would want the same detail before I acted on it either.
Adducts: sodium, potassium, and the peak you did not expect Replied, post #77 · Analytics › Mass spectrometry · 23 Apr 2025 · 0 likes Adding the measurement that post #76 says would settle it. Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a…
Retatrutide dose escalation in the published trials Replied, post #108 · Compounds › Retatrutide · 9 Apr 2025 · 26 likes Building on post #105 rather than restating it. Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step…
Why cagrilintide alone is discussed so much less than in combination Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 0 likes Cagrilintide alone is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
A promotion I argued against, and why I lost Replied, post #132 · Documentation › Doc review · 14 Mar 2025 · 23 likes This settles it for me, at least until somebody posts a reason it should not.
Charge states for a 4 kDa peptide, worked through Replied, post #13 · Analytics › Mass spectrometry · 3 Mar 2025 · 8 likes Post #11 describes the usual case. This is about the unusual one. Second-hand on charge states, so weight it accordingly — someone whose method I trust told me this and…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Started this topic · Clinical › Comorbidities · 2 Mar 2025 · 2 likes Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight…
Coming back to: Official shortage notices and what they authorise Replied, post #18 · Access › Shortages · 14 Feb 2025 · 12 likes Thank you — that answers what I came here to find out.
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #33 · Clinical › Bloodwork · 27 Jan 2025 · 14 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. The failure mode on Lipid changes during rapid weight is boring…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #31 · Evidence › Journal club · 24 Jan 2025 · 3 likes I would put moderate confidence on the mainstream reading of SUSTAIN 6 and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
How compounding permissions changed when supply normalised Replied, post #10 · Sourcing › Regulatory · 19 Jan 2025 · 9 likes On post #8 — agreed on the reasoning, with one qualification. The failure mode on compounding permissions is boring rather than dramatic. It is almost always the step…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #49 · Data & Tools › Calculators · 12 Jan 2025 · 5 likes Everything in post #45 holds. The case it does not cover is the one I have. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A…
Books and papers worth reading that are not about this at all Replied, post #10 · Lounge › Off topic · 4 Jan 2025 · 0 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
What a seizure notice actually says Replied, post #16 · Sourcing › Logistics · 16 Dec 2024 · 20 likes Notice of a delay before the quoted window elapses is a materially different service experience from notice afterwards, and it is worth recording which happened. That…
When "no data" is the complete and final answer Replied, post #36 · Compounds › Other compounds · 7 Dec 2024 · 10 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #31 · Compounds › Other compounds · 2 Dec 2024 · 26 likes Colour in a lyophilised cake is worth noting for the less common compounds specifically, because some of them are genuinely not white and a member expecting white will…
Follow-up: Reporting a discrepancy without making an allegation Replied, post #2 · Sourcing › Vendor reports · 5 Nov 2024 · 11 likes Selective submission and selective reporting are the two easiest ways for a result to be shaped, and blinding addresses the first while a commitment to post addresses…
The topic list is dense — is that deliberate? Replied, post #40 · Meta › Site feedback · 18 Oct 2024 · 5 likes Worth stating the null on topic list before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #55 · Evidence › Journal club · 26 Sep 2024 · 2 likes Post #52 and I disagree about the size of the effect, not about the direction. Reporting rather than recommending, on SURPASS-2. What happened is above. Whether it…
People with a low starting BMI: where the evidence stops Replied, post #3 · Clinical › Special populations · 21 Sep 2024 · 3 likes The opening post is the version of this I will quote in future. One addition. Almost every population discussed here was excluded from the pivotal trials, which means…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #34 · Clinical › Bloodwork · 16 Sep 2024 · 10 likes I read post #32 twice before replying, because I had assumed the opposite. A definition problem is doing most of the work in this bring a laboratory discussion. Once…
Correlation in a self-tracked dataset: what it can support Replied, post #97 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Post #96 is right about the mechanism and I think understates the practical bit. Correlation came up in a thread eighteen months ago and was answered well. I cannot…
Correlation in a self-tracked dataset: what it can support Replied, post #72 · Research Methods › Statistics · 23 Aug 2024 · 0 likes The version of correlation that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #8 · Compounds › Oral incretins · 1 Aug 2024 · 2 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
Reading a meta-analysis you disagree with, fairly Started this topic · Evidence › Meta-analyses · 12 Jun 2024 · 37 likes Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I would like to disagree…